---
title: "Director Robert C. Malenka Reports Disposal of Maplight Therapeutics Inc. Common Shares"
description: "Director Robert C. Malenka has reported the disposal of common shares of Maplight Therapeutics Inc. The full filing is accessible via the provided link. This news was generated by Public Technologies "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274371236.md"
published_at: "2026-01-31T01:51:30.000Z"
---

# Director Robert C. Malenka Reports Disposal of Maplight Therapeutics Inc. Common Shares

> Director Robert C. Malenka has reported the disposal of common shares of Maplight Therapeutics Inc. The full filing is accessible via the provided link. This news was generated by Public Technologies (PUBT) and is intended for informational purposes only, not as financial or legal advice. The original content was published by Maplight Therapeutics Inc. through EDGAR on January 30, 2026.

Robert C. Malenka, Director, reported a disposal of common shares of Maplight Therapeutics Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002021198-26-000003), on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MPLT.US - MapLight Therapeutics](https://longbridge.com/en/quote/MPLT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 董事 Robert C. Malenka 報告出售 Maplight Therapeutics Inc.的普通股 | 羅伯特·C·馬倫卡（Robert C. Malenka），Maplight Therapeutics Inc. 的董事，已報告出售該公司的普通股。完整的文件可通過提供的鏈接獲取。此新聞簡報由公共技術公司生成，僅供信息參考，不應被視為財務、投 | [Link](https://longbridge.com/en/news/274900553.md) |
| NVR 公司的一位董事出售了 200 股股票 | NVR 董事 Susan Williamson Ross 於 2026 年 2 月 13 日以每股 7,922.06 美元的價格出售了 200 股 NVR, Inc.普通股，總計 1,584,412 美元。交易後，Ross 直接持有 386 | [Link](https://longbridge.com/en/news/276156708.md) |
| Cibc World Market Inc. 向 QXO, Inc. 投資了 122 萬美元 | Cibc World Market Inc. 在其 13F 文件中報告，已通過在第三季度收購 64,153 股投資了 122 萬美元於 QXO, Inc. 其他機構投資者，包括先鋒集團和 Affinity Partners，也增加了他們在  | [Link](https://longbridge.com/en/news/276106337.md) |
| 活躍股票：Appili Therapeutics Inc | 美國東部時間上午 09:56 - Appili Therapeutics Inc.：已完成其先前宣佈的非承銷私人配售的第二部分，總收入為 100,000 美元。Appili Therapeutics Inc.的股票 T.APLI 目前交易價 | [Link](https://longbridge.com/en/news/276243845.md) |
| Atossa Therapeutics 完成了反向股票拆分 | Atossa Therapeutics Inc. 已於 2026 年 2 月 2 日完成了一次反向股票拆分，以重新符合納斯達克上市要求。這一舉措是公司維持其上市地位戰略的一部分 | [Link](https://longbridge.com/en/news/275612646.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.